Last reviewed · How we verify

NCT01637688: CMPA

Growth and Plasma Amino Acids in Infants With CMPA and Treated With a Newly Innovated Amino Acid Formula

Status unknown Last updated 24 March 2023
What this trial tests

trial testing Comparison of treatment with different amino acid formulas in Cow Milk Allergy in 81 participants. Status unknown.

Timeline
1 April 2013
Primary endpoint
30 June 2023
31 July 2023

Quick facts

Lead sponsorMahidol University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment81
Start date1 April 2013
Primary completion30 June 2023
Estimated completion31 July 2023
Sites1 location across Thailand

Drugs / interventions tested

Conditions studied

Sponsor

Mahidol University

Who can join

Adults 1 Week to 6 Months, any sex, with Cow Milk Allergy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine growth and protein status of infants with cow's milk protein allergy and treated with a newly innovated amino acid formula compared to those with a commercial amino acid formula.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cow Milk Allergy

Currently open trials in the same condition.

Other Mahidol University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01637688.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing